awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48785648-CBFA93CE-96D4-4BC2-B6B8-161A3E95C024
Q48785648-CBFA93CE-96D4-4BC2-B6B8-161A3E95C024
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48785648-CBFA93CE-96D4-4BC2-B6B8-161A3E95C024
Increased disability and MRI lesions after discontinuation of IFN-beta-1a in secondary progressive MS.
P2860
Q48785648-CBFA93CE-96D4-4BC2-B6B8-161A3E95C024
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48785648-CBFA93CE-96D4-4BC2-B6B8-161A3E95C024
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d676e234a5b85457679114f6ae691dbfeef19512
P2860
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.